Articles from Adverse Event Reporting News (June 17, 2008)

Title	Author	Type	Words
Acomplia linked to deaths since approval in U.K.			492
Anemia drugs may speed growth of cancer.			315
Bush formally asks Congress for $275 million to enhance drug safety; Spector critical of funds timing.			537
Consumers lawsuits target drug ads.		Brief article	267
Democrats preparing liability legislation.			843
Drop in FDA warning letters points to shift in enforcement.			599
Drug companies drain scientific brains from FDA, leaving less confident staff.			495
Epilepsy drugs draw industry defense.			636
EU urges more collaboration after heparin scandal.			323
FDA announces labeling changes for Regranex.			453
FDA issues warning on mercury fillings.			662
FDA requests boxed warnings on older class of antipsychotic drugs.			664
FDA reviewing arthritis drugs for childhood cancer link.			348
FDA, facing criticism, bars doctors from drug trials.			754
Grassley asks FDA to probe Glaxo's Paxil communication.		Brief article	278
Grassley, Barton press FDA on priorities of OCI.			616
Health Canada warns about medical devices with heparin coating.			350
Joint FDA-EMEA effort seen yielding extra safety data for drug approval.	Mashaw, Rebecca		675
Lilly criticized for new Evista ads.			683
Merck faces expanded class in Canadian Vioxx lawsuit.			392
NJ court dismisses Vioxx medical monitoring suit.			404
Researchers fail to reveal full drug pay.			1099
Single lot of morphine recalled due to double dosage.		Brief article	180
Six dead in China after drug injection.		Brief article	136